Comparative Molecular Field Analysis on a Set of Muscarinic Agonists

A three-dimensional quantitative structure-activity relationship (3D-QSAR) was carried out on a set of 39 non-congeneric muscarinic agonists using Comparative Molecular Field Analysis (CoMFA). The compounds were tested on the M3 receptor subtype. However, since most of these ligands are reported as unspecific muscarinic agents, the proposed pharmacophore model accounts for features common to all the receptor populations (M1, M2 and M3). In order to define an alignment rule for the superimposition of the ligands, a common pharmacophore frame was derived with a preliminary conformational search performed on four typical muscarinic agonists. Both the steric and the electrostatic fields were used in CoMFA as molecular descriptors and were found relevant with almost the same statistical weight. The CoMFA coefficient contour maps revealed consistency with our postulated mechanism of interaction. Several 3D-QSARs were derived by means of the Partial Least Squares (PLS) method choosing the proper dimensionality with a cross-validation procedure.

[1]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[2]  N. Birdsall,et al.  Muscarinic receptor subtypes. , 1990, Annual review of pharmacology and toxicology.

[3]  L L Iversen,et al.  Novel quinuclidine-based ligands for the muscarinic cholinergic receptor. , 1990, Journal of medicinal chemistry.

[4]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[5]  A. Höskuldsson PLS regression methods , 1988 .

[6]  D. E. Patterson,et al.  Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies , 1988 .

[7]  Dorica Mayer,et al.  A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies , 1987, J. Comput. Aided Mol. Des..

[8]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[9]  M. Sabio,et al.  Recognition of cholinergic agonists by the muscarinic receptor. 1. Acetylcholine and other agonists with the NCCOCC backbone. , 1983, Journal of medicinal chemistry.

[10]  J. G. Vinter,et al.  Strategic approaches to drug design. I. An integrated software framework for molecular modelling , 1987, J. Comput. Aided Mol. Des..

[11]  S. Takemura Geometry of muscarinic agonists. , 1984, Journal of pharmacobio-dynamics.

[12]  M. Dewar,et al.  Ground States of Molecules. 38. The MNDO Method. Approximations and Parameters , 1977 .